Methylphenidate and the risk of psychosis in adolescents and young adults: a population-based cohort study

BACKGROUND: There is a clinical concern that prescribing methylphenidate, the most common pharmacological treatment for attention-deficit hyperactivity disorder (ADHD), might increase the risk of psychotic events, particularly in young people with a history of psychosis. We aimed to determine whethe...

Descripción completa

Detalles Bibliográficos
Autores principales: Hollis, Chris, Chen, Qi, Chang, Zheng, Quinn, Patrick D, Viktorin, Alexander, Lichtenstein, Paul, D'Onofrio, Brian, Landén, Mikael, Larsson, Henrik
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6646837/
https://www.ncbi.nlm.nih.gov/pubmed/31221557
http://dx.doi.org/10.1016/S2215-0366(19)30189-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6646837/
https://www.ncbi.nlm.nih.gov/pubmed/31221557
http://dx.doi.org/10.1016/S2215-0366(19)30189-0

Ejemplares similares